Zurueck zur Suche

Reporte zur Charge U011149

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 3 IN 3 WA 2 WI 2 IA 1 AZ 1 SC 1 OH 1 DE 1 IL 1

VAERS 2177434

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

schwer
Staat
-
Alter
25,0
Geschlecht
F
Eingang
14.03.2022
Impfdatum
14.03.2022
Beginn
14.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure increased Dizziness Fear of injection Pallor Syncope

Symptomtext

The patient started to feel light headed and her face became pale and slowly collapsed about 5 minutes after vaccination. She was seated on a chair and I was by her side, so she did not hit anywhere on her body. Her body was laid flat on the floor and her legs elevated and she started to be able to answer questions. Her BP was 90/48 at the time of syncope and was seen by a doctor. She was monitored on a reclining chair and her BP rose up to 102/54 after 15 minutes of being monitored. She stated that she has never had syncope but admitted that she was scared of needles and has never had more than 3 shots at the same time, and she did not eat anything in the morning so she was already a little light headed when she came to the clinic. She was monitored for additional 15 more minutes on a chair with her husband and she stated that she felt much better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2399424

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

moderat
Staat
CA
Alter
5,0
Geschlecht
M
Eingang
02.08.2022
Impfdatum
02.08.2022
Beginn
02.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dyspnoea Oxygen saturation decreased

Symptomtext

Shortness of breath, low O2 saturation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2416136

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

mild
Staat
IA
Alter
1,0
Geschlecht
F
Eingang
19.08.2022
Impfdatum
29.07.2022
Beginn
06.08.2022
Tage bis Beginn
8,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pyrexia Rash

Symptomtext

Patient developed rash starting about 7 days after the vaccine that appeared very consistent with measles type rash. She also had low grade fevers initially with the rash. Not bothered by the rash at all. No one else in the home or daycare developed similar rash.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hemangioma to right calf
Andere Medikamente
tylenol as needed
Allergien
None
Vorherige Impfungen
-

VAERS 2373875

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

mild
Staat
AZ
Alter
4,0
Geschlecht
M
Eingang
19.07.2022
Impfdatum
11.07.2022
Beginn
11.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Rash Rash erythematous Swelling

Symptomtext

Rash located on Right Upper Arm, noted on 7/11/2022, it is pink in color. it is associated with mild swelling but NO discharge, Itching, loss of sensation, numbness, pain, redness, pus, tingling sensation, fever and no Lymphadeopathy. Condition does not seem to get better with any measure. No prior consultation or treatment tried. No history of travel.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Epistaxis
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2165728

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

mild
Staat
IN
Alter
48,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
04.03.2022
Beginn
05.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Nausea Urticaria

Symptomtext

Patient states he broke out in Hives from head to toe, felt dizzy and nauseous. Took OTC Benadryl. Hives gone,. As of 3/8, still felt slightly Nauseous and dizzy, but improving.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None known
Vorherige Impfungen
-

VAERS 2148516

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

mild
Staat
SC
Alter
1,3
Geschlecht
M
Eingang
28.02.2022
Impfdatum
17.02.2022
Beginn
26.02.2022
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Rash Restlessness

Symptomtext

Rash on legs that spread to face, back and arms. Started on 2/26/2022, low grade fever with temperature reaching a max of 100.9 and restless at night on 2/26/22 and 2/27/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2663406

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
WA
Alter
-
Geschlecht
F
Eingang
31.07.2023
Impfdatum
06.07.2023
Beginn
06.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/no PQC.; HCP calling to report AE for MMRII being given after its expiration date.; This spontaneous report was received from a medical assistant and referred to a 49-year-old female patient. The patient's concurrent conditions, pertinent medical history and drug reactions/allergies were not reported. Concomitant medications included sterile diluent. On 06-JUL-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (therapy type: Albumin status rHA (recombinant Human albumin)), 0.5 milliliter, lot #U011149, expiration date: 08-APR-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). Product has had no previous temperature excursions. Patient had no side effects reported. No additional adverse event (AE) (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2656682

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
WA
Alter
49,0
Geschlecht
F
Eingang
15.07.2023
Impfdatum
06.07.2023
Beginn
06.07.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Administered expired vaccine. No reaction by patient Administered 7/6/2023 expired 4/8/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
no
Vorgeschichte
Hypothyroidism
Andere Medikamente
Armour thyroid, cetirizine, Vitamin D, probiotic
Allergien
NO
Vorherige Impfungen
-

VAERS 2634351

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
19.05.2023
Impfdatum
12.05.2023
Beginn
12.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Caller reporting an expired MMRII was administered to a patient.; This spontaneous report was received from a nurse and referred to a patient of unknown age and gender. The patient's concomitant medication, current condition, pertinent medical history and drug reactions/ allergies were not reported. On 12-MAY-2023, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status: recombinant human albumin (rHA)) (M-M-R II) (0.5 milliliter, lot # U011149, expiration date 08-APR-2023, strength and route of administration were not provided) for prophylaxis (Expired product administered). There was no temperature excursion before administration. No additional adverse event (AE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2631124

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
IN
Alter
1,3
Geschlecht
F
Eingang
12.05.2023
Impfdatum
12.05.2023
Beginn
12.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Patient was given a vaccine that was expired on 4/8/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2626074

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
04.05.2023
Impfdatum
20.04.2023
Beginn
20.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs or PQC reported.; Caller reported expired dose of MMR II was administered. No other information provided. No additional AEs or PQC reported.; This spontaneous report was received from a nurse referring to a patient of unknown gender and age. Information of the patient's pertinent medical history, concurrent condition and drug reactions/allergies was not reported. Concomitant therapy included sterile diluent (manufacturer unknown). On 20-APR-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (therapy type: rHA, 0.5 milliliter, lot #U011149, expiration date: 08-APR-2023, strength was not reported) subcutaneously for prophylaxis (expired product administered). No additional AEs or PQC reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2617983

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
DE
Alter
-
Geschlecht
U
Eingang
20.04.2023
Impfdatum
17.04.2023
Beginn
17.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; patient was accidently administered an expired dose of MMR II on Apr 17, 2023.; This spontaneous report was received from Pharmacist and refers to a patient of an unknown age or gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. 17-APR-2023, the patient was vaccinated with an expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) once, lot #U011149, expiration date: 08-APR-2023, administered for prophylaxis (strength, and route of administration were not provided (Expired vaccine used). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2616422

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
18.04.2023
Impfdatum
10.04.2023
Beginn
10.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Caller inadvertently administered STERILE DILUENT Reconstituted Expired MMRII to Patient on 04/10/2023; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided. On 10-APR-2023, the patient was inadvertently administered with expired vaccine of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, lot #U011149, expiration date: 08-APR-2023, administered for prophylaxis (strength, route of administration, vaccination scheme frequency, anatomical location, and dose were not reported) (expired product administered), which was reconstituted with sterile diluent (lot# W010864, expiry date 23-OCT-2024) (strength and dose were not reported). No Temperature Excursion reported. No additional adverse event reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2602673

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
IL
Alter
1,5
Geschlecht
M
Eingang
23.03.2023
Impfdatum
16.12.2022
Beginn
16.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blister Gianotti-Crosti syndrome

Symptomtext

Multiple vesicles that developed on my son?s arms, hands and legs but spared his torso. Was told this is a Gianotti Crosti Syndrome. Lasted 2-3 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blister
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No
Vorherige Impfungen
-

VAERS 2428183

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
CA
Alter
1,0
Geschlecht
M
Eingang
02.09.2022
Impfdatum
01.09.2022
Beginn
01.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration

Symptomtext

New MA inadvertently give MMR and Varicella IM rather than SQ

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2181349

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
16.03.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation issue

Symptomtext

No adverse event; A dose of M-M-R II was reconstituted with a sterile diluent that is used to reconstitute Act HIB; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Pertinent medical history, drug reactions/allergies and concomitant therapies were not reported. On 03-MAR-2022, a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (rHA) (lot # U011149, expiration date: 08-APR-2023) was reconstituted with a sterile diluent used to reconstitute ActHIB and administered to the patient (0.5 milliliter, unknown route) for prophylaxis. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2157859

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011149

gering
Staat
WI
Alter
1,3
Geschlecht
M
Eingang
04.03.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

MMR vaccine was drawn @ 4:15 on 2/21/22. I gave it @ 12:18 p.m. on 2/22/22 not knowing it could only be in the fridge after reconstituting for a max of 8 hours. I thought it was 24 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-